Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B2 | P19099 | 3/20 | 0.37 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.32 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.32 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.32 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.32 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 5/20 | 0.32 |
| ▸ | MAOB | P27338 | 4/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | KIF11 | P52732 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.31 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21396872 | 0.94 | CYP11B2 (0.37) | CYP11B2GABRA1GABRG2GABRB3GABRA5 | |
| SCHEMBL21378079 | 0.94 | CYP11B2 (0.37) | CYP11B2GABRA1GABRG2GABRB3GABRA5 | |
| SCHEMBL21378015 | 0.91 | GABRA1 (0.34) | CYP11B2GABRA1GABRG2GABRB3GABRA5 | |
| SCHEMBL21378077 | 0.91 | CYP11B2 (0.40) | CYP11B2MAOAMAOBACHECYP2D6 | |
| SCHEMBL21378078 | 0.89 | CYP11B2 (0.38) | CYP11B2MAOAMAOBACHECYP2D6 | |
| SCHEMBL21377927 | 0.88 | CYP11B2 (0.38) | CYP11B2GABRA1GABRG2GABRB3GABRA5 | |
| SCHEMBL21377939 | 0.88 | CYP11B2 (0.38) | CYP11B2GABRA1GABRG2GABRB3GABRA5 | |
| SCHEMBL21377944 | 0.88 | CYP11B2 (0.36) | CYP11B2MAOAMAOBACHECYP2D6 | |
| SCHEMBL21397114 | 0.85 | GABRA1 (0.34) | CYP11B2GABRA1GABRG2GABRB3GABRA5 | |
| SCHEMBL31273957 | 0.85 | CYP11B2 (0.47) | CYP11B2MAOAKIF11KDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11608333-B2 | Composition of matter for use in organic light-emitting diodes | KYULUX, INC. (JP) | 2023-03-21 | — | — | US | disclosed |
| US-20190292181-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | Kyulux North America, Inc. | 2019-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190292181-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | CRY2, SLCO1B3, NDUFV3 | CYP11B2 1221/4885GABRA1 3823/4885GABRG2 3351/4885 |
| US-11608333-B2 | Composition of matter for use in organic light-emitting diodes | CRY2, SLCO1B3, NDUFV3 | CYP11B2 1221/4885GABRA1 3823/4885GABRG2 3351/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.